Edgestream Partners L.P. Makes New $655,000 Investment in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Edgestream Partners L.P. acquired a new position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 54,124 shares of the pharmacy operator’s stock, valued at approximately $655,000.

A number of other large investors also recently added to or reduced their stakes in WBA. Capital World Investors raised its position in shares of Walgreens Boots Alliance by 57.5% in the first quarter. Capital World Investors now owns 29,061,021 shares of the pharmacy operator’s stock valued at $630,334,000 after buying an additional 10,612,373 shares during the last quarter. Thompson Siegel & Walmsley LLC raised its position in shares of Walgreens Boots Alliance by 98.8% in the second quarter. Thompson Siegel & Walmsley LLC now owns 6,021,126 shares of the pharmacy operator’s stock valued at $72,826,000 after buying an additional 2,992,648 shares during the last quarter. Norges Bank acquired a new stake in shares of Walgreens Boots Alliance in the fourth quarter valued at about $29,816,000. Swedbank AB acquired a new stake in shares of Walgreens Boots Alliance in the first quarter valued at about $16,365,000. Finally, Minneapolis Portfolio Management Group LLC acquired a new stake in shares of Walgreens Boots Alliance in the first quarter valued at about $13,710,000. 58.59% of the stock is currently owned by institutional investors and hedge funds.

Walgreens Boots Alliance Trading Down 3.0 %

Shares of WBA stock opened at $8.71 on Friday. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.65 and a quick ratio of 0.31. The firm has a market cap of $7.52 billion, a PE ratio of -1.29, a price-to-earnings-growth ratio of 1.02 and a beta of 0.70. The company has a 50-day moving average of $10.29 and a two-hundred day moving average of $14.72. Walgreens Boots Alliance, Inc. has a 1-year low of $8.46 and a 1-year high of $27.05.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Thursday, June 27th. The pharmacy operator reported $0.63 EPS for the quarter, missing the consensus estimate of $0.68 by ($0.05). Walgreens Boots Alliance had a negative net margin of 3.99% and a positive return on equity of 12.63%. The business had revenue of $36.40 billion during the quarter, compared to analysts’ expectations of $35.94 billion. During the same period in the previous year, the business posted $1.00 EPS. The company’s revenue for the quarter was up 2.8% compared to the same quarter last year. On average, analysts predict that Walgreens Boots Alliance, Inc. will post 2.86 EPS for the current year.

Walgreens Boots Alliance Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, September 12th. Stockholders of record on Wednesday, August 21st were paid a $0.25 dividend. This represents a $1.00 annualized dividend and a dividend yield of 11.48%. The ex-dividend date was Wednesday, August 21st. Walgreens Boots Alliance’s payout ratio is -14.84%.

Analyst Ratings Changes

A number of brokerages have recently commented on WBA. Barclays reduced their target price on shares of Walgreens Boots Alliance from $11.00 to $7.00 and set an “underweight” rating for the company in a research report on Tuesday, July 23rd. Royal Bank of Canada cut their price objective on shares of Walgreens Boots Alliance from $22.00 to $13.00 and set a “sector perform” rating for the company in a research report on Tuesday, July 2nd. TD Cowen cut their price objective on shares of Walgreens Boots Alliance from $22.00 to $16.00 and set a “buy” rating for the company in a research report on Thursday, September 12th. Truist Financial cut their price objective on shares of Walgreens Boots Alliance from $20.00 to $13.00 and set a “hold” rating for the company in a research report on Friday, June 28th. Finally, UBS Group cut their price objective on shares of Walgreens Boots Alliance from $17.00 to $12.00 and set a “neutral” rating for the company in a research report on Wednesday, July 3rd. Four analysts have rated the stock with a sell rating, ten have issued a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $14.73.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.